InvestorsHub Logo
Followers 0
Posts 996
Boards Moderated 0
Alias Born 06/20/2017

Re: DewDiligence post# 47496

Wednesday, 12/27/2017 11:53:43 AM

Wednesday, December 27, 2017 11:53:43 AM

Post# of 108192
Dew, given all the positive news and preliminary results surrounding neoantigen vaccines, why is there not much excitement about the Advaxis implementation? Is there some perceived disadvantage of their approach, or is the only disadvantage that they have not yet started a phase I trial? Are the companies mentioned in this article further ahead in that sense?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News